Linxia Li

85 Wujin Road
Hongkou, 200080, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Corrigendum to "Hyperoside mitigates PCOS-associated adipogenesis and insulin resistance by regulating NCOA2-mediated PPAR-γ ubiquitination and degradation" [Life Sci. 364 (2025) 123417].

Corrigendum to "Hyperoside mitigates PCOS-associated adipogenesis and insulin resistance by regulating NCOA2-mediated PPAR-γ ubiquitination and degradation" [Life Sci. 364 (2025) 123417].

Journal: Life sciences

Published: July 17, 2026

Luteolin alleviates PCOS by inhibiting AR/STAT3/NLRP3-mediated granulosa cell pyroptosis.

Luteolin alleviates PCOS by inhibiting AR/STAT3/NLRP3-mediated granulosa cell pyroptosis.

Journal: Journal of ovarian research

Published: September 02, 2025

Neoadjuvant therapy of iparomlimab and tuvonralimab combined with chemotherapy-extenuated for locally advanced cervical cancer (NICE-CC): an investigator-initiated, multicentre, open-label, phase II trial.

Neoadjuvant therapy of iparomlimab and tuvonralimab combined with chemotherapy-extenuated for locally advanced cervical cancer (NICE-CC): an investigator-initiated, multicentre, open-label, phase II trial.

Journal: Journal of gynecologic oncology

Published: July 28, 2025

Jiawei Zaoqi Decoction Attenuates Polycystic Ovary Syndrome by Inhibiting AGE-RAGE-Mediated Cell Senescence of Granulosa Cells.

Jiawei Zaoqi Decoction Attenuates Polycystic Ovary Syndrome by Inhibiting AGE-RAGE-Mediated Cell Senescence of Granulosa Cells.

Journal: Current pharmaceutical design

Published: July 25, 2025

Pathogenesis and treatment of obesity-related polycystic ovary syndrome.

Pathogenesis and treatment of obesity-related polycystic ovary syndrome.

Journal: Journal of ovarian research

Published: May 03, 2025

Ginsenoside Rb2 improves diminished ovarian reserve through regulation of gonadal hormones and apoptosis via SIRT1.

Ginsenoside Rb2 improves diminished ovarian reserve through regulation of gonadal hormones and apoptosis via SIRT1.

Journal: Journal of ovarian research

Published: March 27, 2025

Hyperoside mitigates PCOS-associated adipogenesis and insulin resistance by regulating NCOA2-mediated PPAR-γ ubiquitination and degradation.

Hyperoside mitigates PCOS-associated adipogenesis and insulin resistance by regulating NCOA2-mediated PPAR-γ ubiquitination and degradation.

Journal: Life sciences

Published: November 12, 2024

The Effect of Circulating Inflammatory Proteins on Endometriosis: A Mendelian Randomization Study.

The Effect of Circulating Inflammatory Proteins on Endometriosis: A Mendelian Randomization Study.

Journal: ImmunoTargets and therapy

Published: August 21, 2024

Atractylodin alleviates polycystic ovary syndrome by inhibiting granule cells ferroptosis through pyruvate dehydrogenase kinase 4-mediated JAK-STAT3 pathway.

Atractylodin alleviates polycystic ovary syndrome by inhibiting granule cells ferroptosis through pyruvate dehydrogenase kinase 4-mediated JAK-STAT3 pathway.

Journal: International immunopharmacology

Published: July 11, 2024

Alantolactone Induced Apoptosis and DNA Damage of Cervical Cancer through ATM/CHK2 Signaling Pathway.

Alantolactone Induced Apoptosis and DNA Damage of Cervical Cancer through ATM/CHK2 Signaling Pathway.

Journal: Biological & pharmaceutical bulletin

Published: July 07, 2024

SIM2: Its Prognostic Significance and Oncogenic Role in Endometrial Carcinoma.

SIM2: Its Prognostic Significance and Oncogenic Role in Endometrial Carcinoma.

Journal: OncoTargets and therapy

Published: September 18, 2023

Clinical effects of IPCH after the surgery for ovarian cancer at the middle or advanced stage and its impacts on tumor markers and immune functions.

Clinical effects of IPCH after the surgery for ovarian cancer at the middle or advanced stage and its impacts on tumor markers and immune functions.

Journal: Pakistan journal of medical sciences

Published: June 24, 2023

Showing 1-12 of 27

Last Updated: 09/26/2026